Extranodal Natural Killer cell/T cell lymphomas are subcategorized into ENK/T-nasal and ENK/T-nasal type. These lymphomas presenting as initial involvement of skin are unusual and are known as Primary cutaneous NK/T -nasal type lymphomas. We present a rare case of a middle aged female presenting with rapidly developing skin nodules and ulcers. This case highlights the fact that adequate work up should be done in all such cases to avoid erroneous diagnosis and subsequent inadequate treatment of primary cutaneous lymphoma patients.
INTRODUCTION
Extranodal NK/T cell lymphoma-Nasal (ENK/T-N) usually involve the upper aerodigestive tract whereas skin, soft tissue, gastro intestinal tract are sites of predilection for Extranodal NK/T cell lymphoma-Nasal Type (ENK/T-NT).
1 Nasal type lymphoma with initial presentation in the skin is known as Primary Cutaneous ENK/T-NT lymphoma (PC-ENK/T-NT). These are rare types of Non Hodgkins Lymphoma characterized by an aggressive clinical course. They account for <2% lymphoma in Europe and North America however a slightly increased frequency is noted in Asia and Central and South America (5-10% of all Non Hodgkins Lymphoma). 2 These tumors show a short survival time and poor response to therapy. 3 The 5 year survival ranges from 37.9% to 45.3% despite intensive chemotherapy followed by radiotherapy. 4 We present this clinically unsuspecting case of NK/T cell lymphoma because of it's rarity, aggressive clinical features and thorough diagnostic work up.
CASE
A 48 year old North Indian female presented to the Dermatology clinic with multiple skin patches and nodules since 2 months. There was no history of fever, night sweats or weight loss. On examination the nodules were mostly present on the extremities, trunk and face. These nodules were erythematous and violaceous ( Figure 1 ). There was no lymphadenopathy, organomegaly or sinonasal involvement. Complete hemogram showed mild anemia (9.8 g/dl) however leukocyte and platelet counts were within normal limits. ELISA for HIV, HBsAg and VDRL were non-reactive. A clinical diagnosis of pyoderma gangrenosum was made. Skin biopsy (4 mm deep) was taken from a nodular lesion in the right forearm and sent for histopathological examination. Biopsy was processed routinely and slide prepared was stained with Hematoxylin and Eosin as well as with Giemsa. Microscopic examination revealed partly atrophic epidermis. Dermis showed sheets of atypical medium to large lymphoid cells with a predominantly angiocentric pattern. Cells had round to convoluted nuclei with coarse chromatin.Mitotic figures were sparse however multiple areas of necrosis admixed with nuclear dust were seen (Photomicrograph 1). A differential diagnosis of lymphoma versus metastatic carcinoma was rendered and Immunohistochemistry (IHC) was performed. IHC showed cytoplasmic CD3 and CD56 positivity and negativity for CK,CD30 and CD20. (Photomicrographs 2,3 5 In the present case, IHC for EBV was not performed however the neoplastic cells were positive for CD56, CD2 and cytoplasmic CD3. Loss of 6q is a frequently reported genomic alteration in ENK/T lymphomas however the significance is not clear. 6 Li et al detected abnormal expression of the p53 protein and mutation of the TP53 gene in a wide range of cases.These genes are involved in the cell cycle, and their loss is described in tumor formation in mosttissues, particularly in cases of leukemia and lymphoma. 7 Some studies have reported that localized cutaneous manifestations are related to a less fulminant course and a better survival outcome. 8, 9 The extent of initial skin involvement does not reliably predict outcome, however if regional lymph nodes are involved the patient may deteriorate more rapidly with a median survival of less than 15 months.
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CONCLUSION
Extranodal cutaneous NK/T cell lymphoma is an aggressive neoplasm. The presence of systemic or nodal disease at presentation is the most important clinical variable and portends a poor prognosis. All cases of rapidly developing erythematous nodules should be further evaluated for an underlying malignant disease. Histopathology with Immunohistochemistry remains the gold standard for making a definite diagnosis.
